FRIDAY, Dec. 10, 2021 (American Heart Association News) — The holidays are a time to share home-cooked meals, reconnect with far-away loved ones and contemplate what the next year has in store. But for nearly two years, the coronavirus pandemic has affected our ability to safely get together in person. With vaccines now widely available… read on > read on >
The Omicron variant could prompt a reshuffling of the way doctors treat COVID infections in the United States, and antiviral pills will likely lead the way in that redoubled effort, Harvard experts say. New antiviral pills developed by Merck and Pfizer are expected to remain effective against the Omicron variant, mostly because they interfere with… read on > read on >
Cutting-edge mRNA technology brought safe, effective COVID-19 vaccines to a world in crisis — could it do the same for a much older foe, HIV? An experimental HIV vaccine that uses the same mRNA platform technology as the Pfizer and Moderna COVID-19 vaccines shows promise in animals, a new U.S. government-led study finds. “Despite nearly… read on > read on >
The world isn’t ready to prevent or deal with another pandemic because many nations aren’t taking the necessary steps to prepare for what is likely an inevitable future scenario, a new report shows. The Global Health Security (GHS) index — an assessment of preparedness for various health emergencies and problems — is produced by the… read on > read on >
“Fights off tumors and alleviates symptoms of chemotherapy,” one vape’s advertising claims, while another is touted as an “asthma remedy, ADHD remedy, and dementia treatment.” Don’t believe the hype. Despite claims that certain vaping products may alleviate health problems, there’s no proof that they do — and they may even cause health issues, the U.S.… read on > read on >
Cancer patients are at risk for serious COVID-19 illness, but some are still afraid to get vaccinated against the virus, new research shows. Study authors surveyed nearly 200 high-risk cancer patients at the Mays Cancer Center in San Antonio, Texas. Only 56% said they’d received at least one COVID-19 vaccine dose, compared to the community… read on > read on >
U.S. operating rooms got busy once again soon after the first round of pandemic shutdowns, according to a study that challenges the widely held belief that operations have been curtailed indefinitely during the age of COVID-19. “It’s an untold story,” said senior study author Dr. Sherry Wren, a professor of general surgery at Stanford University… read on > read on >
Children with hard-to-control asthma may get relief from adding an injectable antibody drug to their standard treatment, a clinical trial has found. The drug, called dupilumab (Dupixent), has been available for several years to treat stubborn asthma in adults and teenagers. Based on the new findings, the U.S. Food and Drug Administration recently gave it… read on > read on >
What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who had high levels of inflammation-causing bacteria in their intestinal tract may have had a greater risk for contracting… read on > read on >
The U.S. Food and Drug Administration on Wednesday granted emergency approval of a new antibody cocktail to prevent COVID infection in people who have weakened immune systems or who can’t tolerate COVID vaccines. “Vaccines have proven to be the best defense available against COVID-19. However, there are certain immune-compromised individuals who may not mount an… read on > read on >
-300x200.jpeg)
